Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Driven by takeover offers for Ashtead Technology and Lifecore Biomedical, while completely divesting Lifecore following an unattractive deal structure.
Full Quick Take
Driven by takeover offers for Ashtead Technology and Lifecore Biomedical, while completely divesting Lifecore following an unattractive deal structure.
Third Avenue Value Fund underperformed in Q2 2026 as markets chased semiconductors and AI while the Fund stayed disciplined in out-of-favor tangible asset plays.
Full Quick Take
Third Avenue Value Fund underperformed in Q2 2026 as markets chased semiconductors and AI while the Fund stayed disciplined in out-of-favor tangible asset plays.